{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:angiotensin-receptor-blockers-arbs",
  "owner": "cardio",
  "kind": "drug",
  "slug": "angiotensin-receptor-blockers-arbs",
  "name": "Angiotensin receptor blockers (ARBs)",
  "aliases": [
    "ARBs",
    "ARB",
    "Angiotensin II receptor blockers",
    "Angiotensin receptor blockers",
    "Angiotensin receptor blocker"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A class of medicines that block the receptor that angiotensin II acts on. MeSH notes that some of them are used as blood pressure lowering agents. The US label read for one ARB lists high blood pressure in adults and children, lowering the risk of stroke in people who have high blood pressure and left ventricular hypertrophy (the label says there is evidence that this benefit does not apply to Black patients), and a kidney disease of type 2 diabetes in people with a history of high blood pressure. It also carries a boxed warning that these drugs can cause injury and death to the developing fetus.",
  "summary_technical": "Class page. MeSH descriptor D047228 (Angiotensin II Type 1 Receptor Blockers, last updated 2020-05-27) is an exact match, and its scope note gives the class description. The label read is the US prescribing label of one brand-name losartan potassium tablet (application NDA020386, effective 2026-01-20 in openFDA). It calls the medicine an angiotensin II receptor blocker. Its first list of uses says children greater than 6 years old, while the detailed hypertension text says pediatric patients 6 years of age and older; both are kept side by side. The label says the stroke benefit has evidence that it does not apply to Black patients. A separate claim records the boxed warning on fetal toxicity; the recipient of that risk is the fetus. One label stands for one product, so other members of the class may list other uses, and no other label was read. This page gives no dose, no trial result and no guideline statement. Medicines of the class that have their own pages are filed under it.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D047228",
      "normalized_value": "D047228",
      "match": "exact",
      "version": "MeSH linked-data descriptor record fetched on 2026-11-09, lastUpdated 2020-05-27; the record states no yearly MeSH release",
      "label": "Angiotensin II Type 1 Receptor Blockers",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels"
      ],
      "condition-area": [
        "hypertension"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "MeSH says these agents antagonize the angiotensin II type 1 receptor. A US label says the medicine and its active metabolite block the vasoconstrictor and aldosterone-secreting effects of angiotensin II."
  },
  "content_digest": "535c4a0337f49694655bf3902ccd148b35a5ba74b840c493a28c7c297c25318d",
  "review": {
    "content_digest": "535c4a0337f49694655bf3902ccd148b35a5ba74b840c493a28c7c297c25318d",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-cozaar-label-boxed-warning",
      "owner": "cardio",
      "subject_entity_id": "cardio:angiotensin-receptor-blockers-arbs",
      "category": "safety",
      "statement": "The same US label of COZAAR carries a boxed warning titled fetal toxicity. It says that drugs acting directly on the renin-angiotensin system can cause injury and death to the developing fetus.",
      "context": {
        "id": "cardio:ctx-fda-cozaar-label-fetal-risk",
        "label": "The developing fetus, for a person taking an ARB during pregnancy, as described in a US label boxed warning",
        "recipient": "fetal",
        "population": "The developing fetus when a pregnant person takes the medicine, as the label boxed warning describes the risk. The warning is not about the person who takes the medicine.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Fetus during pregnancy; the passage read gives no gestational ages",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Pregnancy during which the medicine is taken (risk to the fetus)"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records the fetal-risk statement of the label's boxed warning only. The warning also tells prescribers what to do when pregnancy is detected; that instruction is not repeated here. Other warnings, contraindications and interactions of the label were not recorded, and no pregnancy or lactation guidance is given. Labels change, and openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0]",
          "applicability_note": "The boxed warning title and its fetal-injury statement.",
          "snapshot": {
            "id": "cardio:openfda-label-cozaar-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:34Z",
            "content_hash": "536990a875d291986fb51dbf7b10cf8ee959b18f260426b2261c43216a2378f9",
            "source_effective_date": "2026-01-20",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-cozaar",
            "source_type": "regulator",
            "title": "openFDA drug label record for COZAAR (losartan potassium tablets), Organon LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%229949448f-c3b9-44ee-94ed-c1aca8c90f39%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 9949448f-c3b9-44ee-94ed-c1aca8c90f39 (manufacturer Organon LLC, application NDA020386), returned on 2026-11-09. The label text is dated 2026-01-20 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-cozaar.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20260120.",
          "snapshot": {
            "id": "cardio:openfda-label-cozaar-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:34Z",
            "content_hash": "536990a875d291986fb51dbf7b10cf8ee959b18f260426b2261c43216a2378f9",
            "source_effective_date": "2026-01-20",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-cozaar",
            "source_type": "regulator",
            "title": "openFDA drug label record for COZAAR (losartan potassium tablets), Organon LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%229949448f-c3b9-44ee-94ed-c1aca8c90f39%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 9949448f-c3b9-44ee-94ed-c1aca8c90f39 (manufacturer Organon LLC, application NDA020386), returned on 2026-11-09. The label text is dated 2026-01-20 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-cozaar.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "bd38796ef07cda033b9ba07b14f6dc24d01ac22fbf198846f909c44cde1c4435",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-cozaar-label-boxed-warning.json"
    },
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-cozaar-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:angiotensin-receptor-blockers-arbs",
      "category": "descriptive",
      "statement": "The US label of COZAAR (losartan potassium tablets, Organon LLC, application NDA020386; the version dated 2026-01-20 in openFDA) calls the medicine an angiotensin II receptor blocker (ARB). It lists treating hypertension in adults and pediatric patients 6 years of age and older, reducing the risk of stroke in patients with hypertension and left ventricular hypertrophy, and treating diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. The label says there is evidence that the stroke benefit does not apply to Black patients. MeSH says the class antagonizes the angiotensin II type 1 receptor and that some of its members are used as antihypertensive agents.",
      "context": {
        "id": "cardio:ctx-fda-cozaar-label-us",
        "label": "People with hypertension (adults and pediatric patients 6 years and older), hypertension with left ventricular hypertrophy, or diabetic nephropathy in type 2 diabetes, as described in the US label of an ARB",
        "recipient": "mixed",
        "population": "Patients described in the indications section of the label: adults and pediatric patients 6 years of age and older with hypertension, patients with hypertension and left ventricular hypertrophy, and patients with type 2 diabetes, a history of hypertension, an elevated serum creatinine and proteinuria.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Adults, and for hypertension also pediatric patients 6 years of age and older, as the label states",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adults and pediatric patients 6 years of age and older with hypertension",
            "Hypertension with left ventricular hypertrophy",
            "Type 2 diabetes with a history of hypertension, elevated serum creatinine and proteinuria (diabetic nephropathy)"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label's first list says children greater than 6 years old, while its detailed hypertension text says pediatric patients 6 years of age and older; the two were not reconciled. Other ARB labels list different uses. The label's contraindications, other warnings, interactions and dosing were not recorded; its boxed warning is recorded in a separate claim. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that call the medicine an ARB and list its uses.",
          "snapshot": {
            "id": "cardio:openfda-label-cozaar-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:34Z",
            "content_hash": "536990a875d291986fb51dbf7b10cf8ee959b18f260426b2261c43216a2378f9",
            "source_effective_date": "2026-01-20",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-cozaar",
            "source_type": "regulator",
            "title": "openFDA drug label record for COZAAR (losartan potassium tablets), Organon LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%229949448f-c3b9-44ee-94ed-c1aca8c90f39%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 9949448f-c3b9-44ee-94ed-c1aca8c90f39 (manufacturer Organon LLC, application NDA020386), returned on 2026-11-09. The label text is dated 2026-01-20 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-cozaar.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20260120.",
          "snapshot": {
            "id": "cardio:openfda-label-cozaar-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:34Z",
            "content_hash": "536990a875d291986fb51dbf7b10cf8ee959b18f260426b2261c43216a2378f9",
            "source_effective_date": "2026-01-20",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-cozaar",
            "source_type": "regulator",
            "title": "openFDA drug label record for COZAAR (losartan potassium tablets), Organon LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%229949448f-c3b9-44ee-94ed-c1aca8c90f39%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 9949448f-c3b9-44ee-94ed-c1aca8c90f39 (manufacturer Organon LLC, application NDA020386), returned on 2026-11-09. The label text is dated 2026-01-20 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-cozaar.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value",
          "applicability_note": "MeSH scope note: the class antagonizes the angiotensin II type 1 receptor; some are antihypertensive agents.",
          "snapshot": {
            "id": "cardio:mesh-scope-d047228-2026-11-09",
            "retrieved_at": "2026-11-09T13:15:41Z",
            "content_hash": "854b15d2482adbea17ec622f381141506c3f5275a47ddce16330c4c2365c6e66",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d047228",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D047228 (Angiotensin II Type 1 Receptor Blockers)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0456879",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0456879",
                "normalized_value": "M0456879",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept of descriptor D047228, retrieved 2026-11-09",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0456879 of descriptor D047228, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed at research/snapshots/w4k03-meshc-M0456879.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "5f37e1da55f384553b3131fce839461b551e0f9167def11340878fd1df20312f",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-cozaar-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "A US label lists treating high blood pressure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-cozaar-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "A US label lists diabetic kidney disease in type 2 diabetes as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:diabetic-nephropathy",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-cozaar-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Reading path on high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:reading-path-high-bp",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-cozaar-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Patient guide on high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:guide-new-high-blood-pressure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-cozaar-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Blood pressure lowering medicine, the care strategy",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:bp-lowering-medicine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Heart failure medicine regimen",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:hfref-four-medicine-regimen",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:candesartan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-214354-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:losartan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-52175-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:olmesartan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-321064-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:ranolazine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:telmisartan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-73494-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:valsartan",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-69749-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01377285",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01377285-2016-10-14",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01447654",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01447654-2014-07-09",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01541189",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01541189-2017-03-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01629225",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01629225-2014-11-18",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01912534",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01912534-2021-01-11",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02010905",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02010905-2015-12-22",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03686696",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03686696-2023-11-27",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04330300",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04330300-2020-06-30",
          "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04715568",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04715568-2026-08-19",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04913870",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04913870-2024-12-20",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05321875",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05321875-2024-11-07",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05843162",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05843162-2023-05-06",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct06863987",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06863987-2025-03-07",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct07735130",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07735130-2026-07-29",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/angiotensin-receptor-blockers-arbs/",
  "context_path": "api/v1/context/cardio--angiotensin-receptor-blockers-arbs.md"
}
